So as we consider the scary times of health care reform, the expensive and relatively ineffective therapies we have to offer, we must look to the end of the tunnel, refocus us back on to the goal of curing cancer, and engaging with our partners including patients, the pharmaceutical industry, the federal government, and insurance providers to work together towards our common goal of curing cancers